The Trump administration is pushing hard to make artificial intelligence a core component of medical care across the United States. Federal health officials are actively working to fund and deploy AI agents capable of diagnosing patients and prescribing treatments, a move that is reshaping how the government approaches healthcare, as reported by the New York Times.
This aggressive strategy is centered at the Department of Health and Human Services. While the goal is to improve health outcomes and reduce costs, the rapid pace of development has caused significant friction. Some officials involved in these discussions have expressed deep concerns that the technology is being rolled out without enough evidence to prove it is safe or effective. There is also growing unease regarding the heavy influence of Silicon Valley investors who are suddenly playing a major role in federal health policy.
